Condition
Multidrug Resistance
Total Trials
4
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Completed2
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07004049Phase 4Recruiting
Optimising TREATment for Severe Gram-Negative Bacterial Infections
NCT06634940Recruiting
International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections
NCT03352804CompletedPrimary
Are the Patients Having Pets at Greater Risk of Carrying Multidrug Resistance Bacteriae?
NCT01952158CompletedPrimary
Point Prevalence Study of Multidrug-Resistant Organism Carriage by Healthcare Personnel
Showing all 4 trials